1. Home
  2. PDLB vs VYGR Comparison

PDLB vs VYGR Comparison

Compare PDLB & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

HOLD

Current Price

$20.42

Market Cap

481.1M

Sector

N/A

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.17

Market Cap

216.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDLB
VYGR
Founded
1960
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
481.1M
216.3M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
PDLB
VYGR
Price
$20.42
$3.17
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.50
AVG Volume (30 Days)
63.0K
414.1K
Earning Date
04-24-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
160.87
N/A
EPS
0.71
N/A
Revenue
N/A
$10,135,000.00
Revenue This Year
N/A
$34.04
Revenue Next Year
N/A
$7.92
P/E Ratio
$28.61
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.91
$2.94
52 Week High
$21.10
$5.55

Technical Indicators

Market Signals
Indicator
PDLB
VYGR
Relative Strength Index (RSI) 51.50 41.61
Support Level $19.66 $2.95
Resistance Level $20.81 $3.30
Average True Range (ATR) 0.40 0.15
MACD -0.01 -0.03
Stochastic Oscillator 60.20 10.99

Price Performance

Historical Comparison
PDLB
VYGR

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: